Discounted Cash Flow
Hims & Hers Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $148.8m | $-3.0m | $-777.1k | -2.0% | $-0.51 |
| 2021 | $271.9m (82.8%) | $-107.7m (-3430.9%) | $-34.4m (-4328.4%) | -39.6% (-1831.9%) | $-0.58 (-13.7%) |
| 2022 | $526.9m (93.8%) | $-65.7m (39.0%) | $-33.8m (1.8%) | -12.5% (68.5%) | $-0.32 (44.8%) |
| 2023 | $872.0m (65.5%) | $-23.5m (64.1%) | $47.0m (239.1%) | -2.7% (78.3%) | $-0.11 (65.6%) |
| 2024 | $1.5b (69.3%) | $126.0m (635.3%) | $198.3m (322.1%) | 8.5% (416.1%) | $0.58 (627.3%) |
| 2025 | $2.3b (59.0%) | $128.4m (1.8%) | $57.4m (-71.1%) | 5.5% (-35.9%) | $0.57 (-1.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.